Search Results - "Rottmann, Antje"
-
1
Identification of a Benzimidazolecarboxylic Acid Derivative (BAY 1316957) as a Potent and Selective Human Prostaglandin E2 Receptor Subtype 4 (hEP4-R) Antagonist for the Treatment of Endometriosis
Published in Journal of medicinal chemistry (14-03-2019)“…The presence and growth of endometrial tissue outside the uterine cavity in endometriosis patients are primarily driven by hormone-dependent and inflammatory…”
Get full text
Journal Article -
2
Discovery of Vilaprisan (BAY 1002670): A Highly Potent and Selective Progesterone Receptor Modulator Optimized for Gynecologic Therapies
Published in ChemMedChem (06-11-2018)“…Progesterone plays an important role in the female reproductive system. However, there is also evidence that gynecologic disorders/diseases such as uterine…”
Get full text
Journal Article -
3
Hepatotoxicity of AKR1C3 Inhibitor BAY1128688: Findings from an Early Terminated Phase IIa Trial for the Treatment of Endometriosis
Published in Drugs in R&D (01-09-2023)“…Introduction BAY1128688 is a selective inhibitor of aldo-keto reductase family 1 member C3 (AKR1C3), an enzyme implicated in the pathology of endometriosis and…”
Get full text
Journal Article -
4
The Starch-Related R1 Protein is an α-Glucan, Water Dikinase
Published in Proceedings of the National Academy of Sciences - PNAS (14-05-2002)“…To determine the enzymatic function of the starch-related R1 protein it was heterologously expressed in Escherichia coli and purified to apparent homogeneity…”
Get full text
Journal Article -
5
Metabolism and Disposition of Vatalanib (PTK787/ZK-222584) in Cancer Patients
Published in Drug metabolism and disposition (01-11-2006)“…Vatalanib (PTK787/ZK-222584) is a new oral antiangiogenic molecule that inhibits all known vascular endothelial growth factor receptors. Vatalanib is under…”
Get full text
Journal Article -
6
Pharmacokinetics, Safety, and Tolerability of the Novel Tetrameric, High-Relaxivity, Macrocyclic Gadolinium-Based Contrast Agent Gadoquatrane in Healthy Adults
Published in Investigative radiology (01-02-2024)“…Gadolinium (Gd)-based contrast agents are well established in clinical routine and have been proven safe and effective. However, there is a need for…”
Get full text
Journal Article -
7
Preclinical and Clinical Pharmacokinetics and Bioavailability in Healthy Volunteers of a Novel Formulation of the Selective P2X3 Receptor Antagonist Eliapixant
Published in European journal of drug metabolism and pharmacokinetics (2023)“…Background and Objectives The potent, selective P2X3 receptor antagonist eliapixant (BAY 1817080) is under development for conditions characterized by neuronal…”
Get full text
Journal Article -
8
Quantitative Systems Toxicology Identifies Independent Mechanisms for Hepatotoxicity and Bilirubin Elevations Due to AKR1C3 Inhibitor BAY1128688
Published in Clinical pharmacology and therapeutics (01-11-2023)“…BAY1128688 is a selective inhibitor of AKR1C3, investigated recently in a trial that was prematurely terminated due to drug‐induced liver injury. These…”
Get full text
Journal Article -
9
Clinical Pharmacokinetics and Pharmacodynamics of the Selective Progesterone Receptor Modulator Vilaprisan: A Comprehensive Overview
Published in Clinical pharmacokinetics (01-01-2022)“…Vilaprisan is a highly potent selective progesterone receptor modulator in development for the treatment of symptomatic uterine fibroids and endometriosis. Its…”
Get full text
Journal Article -
10
Novel aldo-keto reductase 1C3 inhibitor affects androgen metabolism but not ovarian function in healthy women: a phase 1 study
Published in European journal of endocrinology (10-07-2023)“…Aldo-keto reductase 1C3 (AKR1C3) has been postulated to be involved in androgen, progesterone, and estrogen metabolism. Aldo-keto reductase 1C3 inhibition has…”
Get full text
Journal Article -
11
The Effects of Weak and Strong CYP3A Induction by Rifampicin on the Pharmacokinetics of Five Progestins and Ethinylestradiol Compared to Midazolam
Published in Clinical pharmacology and therapeutics (01-10-2020)“…It is known that co‐administration of CYP3A inducers may decrease the effectiveness of oral contraceptives containing progestins as mono‐preparations or…”
Get full text
Journal Article -
12
Characterization of the Pharmacokinetics of Vilaprisan: Bioavailability, Excretion, Biotransformation, and Drug–Drug Interaction Potential
Published in Clinical pharmacokinetics (01-08-2018)“…Background and objectives In-vitro data suggest that clearance of vilaprisan is mediated by cytochrome P450 3A4 (oxidation) and aldoketoreductases (reduction)…”
Get full text
Journal Article -
13
A Novel NAMPT Inhibitor-Based Antibody–Drug Conjugate Payload Class for Cancer Therapy
Published in Bioconjugate chemistry (15-06-2022)“…Inhibition of intracellular nicotinamide phosphoribosyltransferase (NAMPT) represents a new mode of action for cancer-targeting antibody–drug conjugates (ADCs)…”
Get full text
Journal Article -
14
Discovery of the potent non-steroidal glucocorticoid receptor modulator BAY 1003803 as clinical candidate
Published in Bioorganic & medicinal chemistry letters (15-08-2020)“…[Display omitted] We report on the discovery of the new clinical candidate BAY 1003803 as glucocorticoid receptor agonist for the topical treatment of…”
Get full text
Journal Article -
15
Mass Balance and Metabolic Pathways of Eliapixant, a P2X3 Receptor Antagonist, in Healthy Male Volunteers
Published in European journal of drug metabolism and pharmacokinetics (2024)“…Background Overactive adenosine triphosphate signaling via P2X3 homotrimeric receptors is implicated in multiple conditions. To fully understand the metabolism…”
Get full text
Journal Article -
16
CYP3A4‐mediated effects of rifampicin on the pharmacokinetics of vilaprisan and its UGT1A1‐mediated effects on bilirubin glucuronidation in humans
Published in British journal of clinical pharmacology (01-12-2018)“…Aims The primary aim of the present study was to quantify the effects of rifampicin, a strong cytochrome P450 (CYP) 3A4 inducer, on the pharmacokinetics of the…”
Get full text
Journal Article -
17
Abstract 2907: Identification and optimization of a novel NAMPT inhibitor-based ADC payload class for cancer therapy
Published in Cancer research (Chicago, Ill.) (15-08-2020)“…Abstract Inhibition of intracellular nicotinamide phosphoribosyltransferase (NAMPT) represents a differentiated mode-of-action for tumor-targeting…”
Get full text
Journal Article -
18
Front Cover: Discovery of Vilaprisan (BAY 1002670): A Highly Potent and Selective Progesterone Receptor Modulator Optimized for Gynecologic Therapies (ChemMedChem 21/2018)
Published in ChemMedChem (06-11-2018)“…The Front Cover shows vilaprisan, a highly selective progesterone receptor modulator (SPRM), bound to the progesterone receptor (PR). Gynecologic diseases such…”
Get full text
Journal Article -
19
Determination of rat serum esterase activities by an HPLC method using S-acetylthiocholine iodide and p-nitrophenyl acetate
Published in Analytical biochemistry (01-10-2008)“…Establishing esterase assays allows the determination and comparison of esteratic activities of tissues of one organism and between organisms. We have…”
Get full text
Journal Article -
20